LEAFY COTYLEDON1 GENES AND THEIR USES

Abstract: The present invention provides nucleic acid sequences from embryo-specific genes. The nucleic acids are useful in targeting gene expression to embryos or in modulating embryo development.

Description: LEAFY COTYLEDON 1 GENES AND THEIR USES FIELD OF THE INVENTION The present invention is directed to plant genetic engineering. In particular, it relates to new embryo-specific genes useful in improving agronomically important plants. BACKGROUND OF THE INVENTION Embryogenesis in higher plants is a critical stage of the plant life cycle in which the primary organs are established. Embryo development can be separated into two main phases: the early phase in which the primary body organization of the embryo is laid down and the late phase which involves maturation, desiccation and dormancy. In the early phase, the symmetry of the embryo changes from radial to bilateral, giving rise to a hypocotyl with a shoot meristem surrounded by the two cotyledonary primordia at the apical pole and a root meristem at the basal pole. In the late phase, during maturation the embryo achieves its maximum size and the seed accumulates storage proteins and lipids. Maturation is ended by the desiccation stage in which the seed water content decreases rapidly and the embryo passes into metabolic quiescent state. Dormancy ends with seed germination, and development continues from the shoot and the root meristem regions. The precise regulatory mechanisms which control cell and organ differentiation during the initial phase of embryogenesis are largely unknown. The plant hormone abscisic acid (ABA) is thought to play a role during late embryogenesis, mainly in the maturation stage by inhibiting germination during embryogenesis (Black, M. (1991). In Abscisic Acid: Physiology and Biochemistry, W. J. Davies and H. G. Jones, eds. (Oxford: Bios Scientific Publishers Ltd.), pp. 99-124) Koornneef, M., and Karssen, C. M. (1994). In Arabidopsis, E. M. Meyerowitz and C. R. Sommerville, eds. (Cold Spring Harbor: Cold Spring Harbor Laboratory Press), pp. 313-334). Mutations which effect seed development and are ABA insensitive have been identified mArabidopsis and maize. The ABA insensitive (abi3) mutant of Arabidopsis and the viviparous 1 (vpl) mutant of maize are detected mainly during late embryogenesis (McCarty, et al., (1989) Plant Cell 1, 523-532 and Parcy et al., (1994) Plant Cell 6, 1567-1582). Both the VP1 gene and the ABI3 genes have been isolated and were found to share conserved regions (Giraudat, J. (1995) Current Opinion in Cell Biology 7:232-238 and McCarty, D. R. (1995). Annu. Rev. Plant Physiol. Plant Mol. Biol. 46:71-93). The VPJ gene has been shown to function as a transcription activator (McCarty, et al., (1991) Cell 66:895-906). It has been suggested that ABB has a similar function. Another class of embryo defective mutants involves three genes: LEAFY COTYLEDON1 and 2 {LEC1, LEC2) and FUSCA3 (FUS3). These genes are thought to play a central role in late embryogenesis (Baumlein, et al. (1994) Plant J. 6:379-387; Meinke, D. W. (1992) Science 258: 1647-1650; Meinke et al, Plant Cell 6: 1049-1064; West et al, (1994) Plant Cell 6: 1731-1745). Like the abi3 mutant, leafy cotyledon-type mutants are defective in late embryogenesis. In these mutants, seed morphology is altered, the shoot meristem is activated early, storage proteins are lacking and developing cotyledons accumulate anthocyanin. As with abi3 mutants, they are desiccation intolerant and therefore die during late embryogenesis. Nevertheless, the immature mutants embryos can be rescued to give rise to mature and fertile plants. However, unlike abi3 when the immature mutants germinate they exhibit trichomes on the adaxial surface of the cotyledon. Trichomes are normally present only on leaves, stems and sepals, not cotyledons. Therefore, it is thought that the leafy cotyledon type genes have a role in specifying cotyledon identity during embryo development. Among the above mutants, the led mutant exhibits the most extreme phenotype during embryogenesis. For example, the maturation and postgermination programs are active simultaneously in the led mutant (West et al. , 1994), suggesting a critical role for LEC1 in gene regulation during late embryogenesis. In spite of the recent progress in defining the genetic control of embryo development, further progress is required in the identification and analysis of genes expressed specifically in the embryo and seed. Characterization of such genes would allow for the genetic engineering plants with a variety of desirable traits. For instance, modulation of the expression of genes which control embryo development may be used to alter traits such as accumulation of storage proteins in leaves and cotyledons. Alternatively, promoters from embryo or seed-specific genes can be used to direct expression of desirable heterologous genes to the embryo or seed. The present invention addresses these and other needs. SUMMARY OF THE INVENTION The present invention is based, in part, on the isolation and characterization of LEC1 genes. The invention provides isolated nucleic acid molecules comprising a LECl polynucleotide sequence, typically about 630 nucleotides in length, which specifically hybridizes to SEQ. ID. No. 1 under stringent conditions. The LECl polynucleotides of the invention can encode a LECl polypeptide of about 210 amino acids, typically as shown in SEQ. ID. No. 2. The nucleic acids of the invention may also comprise expression cassettes containing a plant promoter operably linked to the LECl polynucleotide. In some embodiments, the promoter is from a LECl gene, for instance, as shown in SEQ. ID. No. 3. The LECl polynucleotide may be linked to the promoter in a sense or antisense orientation. The invention also provides transgenic plants comprising an expression cassette containing a plant promoter operably linked to a heterologous LECl polynucleotide. The LECl may encode a LECl polypeptide or may be linked to the promoter in an antisense orientation. The plant promoter may be from any number of sources, including Ά LECI gene, such a as that shown in SEQ. ID. No. 3 or SEQ. ID. No. 4. The transgenic plant can be any desired plant but is often a member of the genus Brassica. Methods of modulating seed development in a plants are also provided. The methods comprise introducing into a plant an expression cassette containing a plant promoter operably linked to a heterologous LECl polynucleotide. The LECl may encode a LECl polypeptide or may be linked to the promoter in an antisense orientation. The expression cassette can be introduced into the plant by any number of means known in the art, including through a sexual cross. The invention further provides expression cassettes containing promoter sequences from LECl genes. The promoters of the invention can be characterized by their ability to specifically hybridizes to a polynucleotide sequence consisting of nucleotides 1 to - 1998 of SEQ. ID. No. 3. The promoters of the invention can be operably linked to a variety of nucleic acids, whose expression is to be targeted to embryos or seeds. Transgenic plants comprising the expression cassettes are also provided. The promoters of the invention can be used in methods of targeting expression of a desired polynucleotide to seeds. The methods comprise introducing into a plant an expression cassette containing a LECl promoter operably linked to a heterologous polynucleotide sequence. Definitions The phrase "nucleic acid" refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. Nucleic acids may also include modified nucleotides that permit correct read through by a polymerase and do not alter expression of a polypeptide encoded by that nucleic acid. The phrase "polynucleotide sequence" or "nucleic acid sequence" includes both the sense and antisense strands as either individual single strands or in the duplex. It includes, but is not limited to, self- replicating plasmids, chromosomal sequences, and infectious polymers of DNA or RNA. The phrase "nucleic acid sequence encoding" refers to a nucleic acid which directs the expression of a specific protein or peptide. The nucleic acid sequences include both the DNA strand sequence that is transcribed into RNA and the RNA sequence that is translated into protein. The nucleic acid sequences include both the full length nucleic acid sequences as well as non-full length sequences derived from the full length sequences. It should be further understood that the sequence includes the degenerate codons of the native sequence or sequences which may be introduced to provide codon preference in a specific host cell. The term "promoter" refers to a region or sequence determinants located upstream or downstream from the start of transcription and which are involved in recognition and binding of RNA polymerase and other proteins to initiate transcription. A "plant promoter" is a promoter capable of initiating transcription in plant cells. Such promoters need not be of plant origin, for example, promoters derived from plant viruses, such as the CaMV35S promoter, can be used in the present invention. The term "plant" includes whole plants, plant organs (e.g. , leaves, stems, flowers, roots, etc.), seeds and plant cells and progeny of same. The class of plants which can be used in the method of the invention is generally as broad as the class of higher plants amenable to transformation techniques, including both monocotyledonous and dicotyledonous plants, as well as certain lower plants such as algae. It includes plants of a variety of ploidy levels, including polyploid, diploid and haploid. A polynucleotide sequence is "heterologous to" an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is different from any naturally occurring allelic variants. As defined here, a modified LECl coding sequence which is heterologous to an operably linked LECl promoter does not include the T-DNA insertional mutants as described in West et al, The Plant Cell 6: 1731-1745 (1994). A polynucleotide "exogenous to" an individual plant is a polynucleotide which is introduced into the plant by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacterium-meάiaiQd transformation, biolistic methods, electroporation, in planta techniques, and the like. Such a plant containing the exogenous nucleic acid is referred to here as an R, generation transgenic plant. Transgenic plants which arise from sexual cross or by selfing are descendants of such a plant. As used herein an "embryo-specific gene" or "seed specific gene" is a gene that is preferentially expressed during embryo development in a plant. For purposes of this disclosure, embryo development begins with the first cell divisions in the zygote and continues through the late phase of embryo development (characterized by maturation, desiccation, dormancy), and ends with the production of a mature and desiccated seed. Embryo-specific genes can be further classified as "early phase-specific" and "late phase- specific". Early phase-specific genes are those expressed in embryos up to the end of embryo morphogenesis. Late phase-specific genes are those expressed from maturation through to production of a mature and desiccated seed. A "LECl polynucleotide" is a nucleic acid sequence comprising (or consisting of) a coding region of about 100 to about 900 nucleotides, sometimes from about 300 to about 630 nucleotides, which hybridizes to SEQ. ID. No. 1 under stringent conditions (as defined below), or which encodes a LECl polypeptide. LECl polynucleotides can also be identified by their ability to hybridize under low stringency conditions {e.g., Tm -40°C) to nucleic acid probes having a sequence from position 1 to 81 in SEQ. ID. NO. 1 or from position 355 to 627 in SEQ. ID. NO. 1. A "promoter from a LECl gene" or "LECl promoter" will typically be about 500 to about 2000 nucleotides in length, usually from about 750 to 1500. An exemplary promoter sequence is shown as nucleotides 1-1998 of SEQ. ID. No. 3. A LEC1 promoter can also be identified by its ability to direct expression in all, or essentially all, proglobular embryonic cells, as well as cotyledons and axes of a late embryo. A "LECl polypeptide" is a sequence of about 50 to about 210, sometimes 100 to 150, amino acid residues encoded by a LECl polynucleotide. A full length LECl polypeptide and fragments containing a CCAAT binding factor (CBF) domain can act as a subunit of a protein capable of acting as a transcription factor in plant cells. LECl polypeptides are often distinguished by the presence of a sequence which is required for binding the nucleotide sequence: CCAAT. In particular, a short region of seven residues (MPIANVI) at residues 34-40 of SEQ. ID No. 3 shows a high degree of similarity to a region that has been shown to required for binding the CCAAT box. Similarly, residues 61-72 of SEQ. ID No. 3 (IQECVSEYISFV) is nearly identical to a region that contains a subunit interaction domain (Xing, et al., (1993) EMBO J. 12:4647-4655). As used herein, a homolog of a particular embryo-specific gene {e.g., SEQ. ID. No. 1) is a second gene in the same plant type or in a different plant type, which has a polynucleotide sequence of at least 50 contiguous nucleotides which are substantially identical (determined as described below) to a sequence in the first gene. It is believed that, in general, homologs share a common evolutionary past. A "polynucleotide sequence from" a particular embryo-specific gene is a subsequence or full length polynucleotide sequence of an embryo-specific gene which, when present in a transgenic plant, has the desired effect, for example, inhibiting expression of the endogenous gene driving expression of an heterologous polynucleotide. A full length sequence of a particular gene disclosed here may contain about 95%, usually at least about 98% of an entire sequence shown in the Sequence Listing, below. In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical and may be "substantially identical" to a sequence of the gene from which it was derived. As explained below, these variants are specifically covered by this term. In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, one of skill will recognize that because of codon degeneracy a number of polynucleotide sequences will encode the same polypeptide. These variants are specifically covered by the term "polynucleotide sequence from" a particular embryo-specific gene, such as LECl. In addition, the term specifically includes sequences {e.g., full length sequences) substantially identical (determined as described below) with a LECl gene sequence and that encode proteins that retain the function of a LECl polypeptide. In the case of polynucleotides used to inhibit expression of an endogenous gene, the introduced sequence need not be perfectly identical to a sequence of the target endogenous gene. The introduced polynucleotide sequence will typically be at least substantially identical (as determined below) to the target endogenous sequence. Two nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The term "complementary to" is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence. Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Add. APL. Math. 2:482 (1981), by the homology alignment algorithm of Needle man and Wunsch J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. (U.S.A.) 85: 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, BLAST, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr., Madison, WI), or by inspection. "Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity. The term "substantial identity" of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 80% sequence identity, preferably at least 85%, more preferably at least 90% and most preferably at least 95%, compared to a reference sequence using the programs described above (preferably BLAST) using standard parameters. One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like. Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40%, preferably at least 60%, more preferably at least 90%, and most preferably at least 95%. Polypeptides which are "substantially similar" share sequences as noted above except that residue positions which are not identical may differ by conservative amino acid changes. Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide- containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur- containing side chains is cysteine and methionine. Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, aspartic acid-glutamic acid, and asparagine-glutamine. Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other, or a third nucleic acid, under stringent conditions. Stringent conditions are sequence dependent and will be different in different circumstances. Generally, stringent conditions are selected to be about 5 ° C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Typically, stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60°C. In the present invention, mRNA encoded by embryo-specific genes of the invention can be identified in Northern blots under stringent conditions using cDNAs of the invention or fragments of at least about 100 nucleotides. For the purposes of this disclosure, stringent conditions for such RNA-DNA hybridizations are those which include at least one wash in 0.2X SSC at 63 °C for 20 minutes, or equivalent conditions. Genomic DNA or cDNA comprising genes of the invention can be identified using the same cDNAs (or fragments of at least about 100 nucleotides) under stringent conditions, which for purposes of this disclosure, include at least one wash (usually 2) in 0.2X SSC at a temperature of at least about 50°C, usually about 55°C, for 20 minutes, or equivalent conditions. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a restriction map of the 7.4 kb genomic wild-type fragment shown in SEQ. ID. No. 4. DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention provides new embryo-specific genes useful in genetically engineering plants. Polynucleotide sequences from the genes of the invention can be used, for instance, to direct expression of desired heterologous genes in embryos (in the case of promoter sequences) or to modulate development of embryos or other organs {e.g., by enhancing expression of the gene in a transgenic plant). In particular, the invention provides a new gene from Arabidopsis referred to here as LECl. LECl encodes polypeptides which subunits of a protein which acts as a transcription factor. Thus, modulation of the expression of this gene can be used to manipulate a number of useful traits, such as increasing or decreasing storage protein content in cotyledons or leaves. Generally, the nomenclature and the laboratory procedures in recombinant DNA technology described below are those well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer's specifications. These techniques and various other techniques are generally performed according to Sambrook et al., Molecular Cloning - A Laboratory Manual, 2nd. ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, (1989). Isolation of nucleic acids of the invention The isolation of sequences from the genes of the invention may be accomplished by a number of techniques For instance, ohgonucleotide probes based on the sequences disclosed here can be used to identify the desired gene in a cDNA or genomic DNA library from a desired plant species To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, e g using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector To prepare a library of embryo-specific cDNAs, mRNA is isolated from embryos and a cDNA library which contains the gene transcripts is prepared from the mRNA The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned embryo-specific gene such as the polynucleotides disclosed here Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques For instance, polymerase chain reaction (PCR) technology to amplify the sequences of the genes directly from mRNA, from cDNA, from genomic libraries or cDNA libraries PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes Appropriate primers and probes for identifying embryo-specific genes from plant tissues are generated from comparisons of the sequences provided herein For a general overview of PCR see PCR Protocols: A Guide to Methods and Applications (Innis, M, Gelfand, D , Sninsky, J and White, T , eds ), Academic Press, San Diego (1990) Appropriate primers for this purpose include, for instance UP primer - 5' GGA ATT CAG CAA CAA CCC AAC CCC A 3" and LP primer - 5' LP primer - 5' GCT CTA GAC ATA CAA CAC TTT TCC TTA 3' Alternatively, the following primer pairs can be used 5' ATG ACC AGC TCA GTC ATA GTA GC 3' and 5' GCC ACA CAT GGT GGT TGC TGC TG 3' or 5' GAG ATA GAG ACC GAT CGT GGT TC 3' and 5' TCA CTT ATA CTG ACC ATA ATG GTC 3' The amplifications conditions are typically as follows Reaction components 10 mM Tris-HCl, pH 8 3, 50 mM potassium chloride, 1 5 mM magnesium chloride, 0.001% gelatin, 200 microM dATP, 200 microM dCTP, 200 microM dGTP, 200 microM dTTP, 0.4 microM primers, and 100 units per ml Taq polymerase. Program: 96 C for 3 min., 30 cycles of 96 C for 45 sec, 50 C for 60 sec, 72 for 60 sec, followed by 72 C for 5 min. Polynucleotides may also be synthesized by well-known techniques as described in the technical literature. See, e.g., Carruthers et al, Cold Spring Harbor Symp. Quant. Biol. 47:411-418 (1982), and Adams et al, J. Am. Chem. Soc. 105:661 (1983). Double stranded DNA fragments may then be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence. Use of nucleic acids of the invention to inhibit gene expression The isolated sequences prepared as described herein, can be used to prepare expression cassettes useful in a number of techniques. For example, expression cassettes of the invention can be used to suppress endogenous LECl gene expression. Inhibiting expression can be useful, for instance, in weed control (by transferring an inhibitory sequence to a weedy species and allowing it to be transmitted through sexual crosses) or to produce fruit with small and non-viable seed. A number of methods can be used to inhibit gene expression in plants. For instance, antisense technology can be conveniently used. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The expression cassette is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been suggested that antisense RNA inhibits gene expression by preventing the accumulation of mRNA which encodes the enzyme of interest, see, e.g., Sheehy et al., Proc. Nat. Acad. Sci. USA, 85:8805-8809 (1988), and Hiatt et al., U.S. Patent No. 4,801,340. The nucleic acid segment to be introduced generally will be substantially identical to at least a portion of the endogenous embryo-specific gene or genes to be repressed. The sequence, however, need not be perfectly identical to inhibit expression. The vectors of the present invention can be designed such that the inhibitory effect applies to other proteins within a family of genes exhibiting homology or substantial homology to the target gene. For antisense suppression, the introduced sequence also need not be full length relative to either the primary transcription product or fully processed mRNA. Generally, higher homology can be used to compensate for the use of a shorter sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and homology of non-coding segments may be equally effective. Normally, a sequence of between about 30 or 40 nucleotides and about full length nucleotides should be used, though a sequence of at least about 100 nucleotides is preferred, a sequence of at least about 200 nucleotides is more preferred, and a sequence of at least about 500 nucleotides is especially preferred. Catalytic RNA molecules or ribozymes can also be used to inhibit expression of embryo-specific genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme sequences within antisense RNAs confers RNA-cleaving activity upon them, thereby increasing the activity of the constructs. A number of classes of ribozymes have been identified. One class of ribozymes is derived from a number of small circular RNAs which are capable of self- cleavage and replication in plants. The RNAs replicate either alone (viroid RNAs) or with a helper virus (satellite RNAs). Examples include RNAs from avocado sunblotch viroid and the satellite RNAs from tobacco ringspot virus, lucerne transient streak virus, velvet tobacco mottle virus, solanum nodiflorum mottle virus and subterranean clover mottle virus The design and use of target RNA-specific ribozymes is described in Haseloff et al. Nature, 334:585-591 (1988). Another method of suppression is sense suppression. Introduction of expression cassettes in which a nucleic acid is configured in the sense orientation with respect to the promoter has been shown to be an effective means by which to block the transcription of target genes. For an example of the use of this method to modulate expression of endogenous genes see, Napoli et al., The Plant Cell 2:279-289 (1990), and U.S. Patents Nos. 5,034,323, 5,231,020, and 5,283, 184. Generally, where inhibition of expression is desired, some transcription of the introduced sequence occurs. The effect may occur where the introduced sequence contains no coding sequence er se, but only intron or untranslated sequences homologous to sequences present in the primary transcript of the endogenous sequence. The introduced sequence generally will be substantially identical to the endogenous sequence intended to be repressed. This minimal identity will typically be greater than about 65%, but a higher identity might exert a more effective repression of expression of the endogenous sequences. Substantially greater identity of more than about 80% is preferred, though about 95% to absolute identity would be most preferred. As with antisense regulation, the effect should apply to any other proteins within a similar family of genes exhibiting homology or substantial homology. For sense suppression, the introduced sequence in the expression cassette, needing less than absolute identity, also need not be full length, relative to either the primary transcription product or fully processed mRNA. This may be preferred to avoid concurrent production of some plants which are overexpressers. A higher identity in a shorter than full length sequence compensates for a longer, less identical sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and identity of non- coding segments will be equally effective. Normally, a sequence of the size ranges noted above for antisense regulation is used. Another means of inhibiting LECl function in a plant is by creation of dominant negatives. In this approach, non-functional, mutant LECl polypeptides, which retain the ability to interact with wild-type subunits are introduced into a plant. Identification of residues that can be changed to create a dominant negative can be determined by published work examining interaction of different subunits of CBF homologs from different species {see, e.g., Sinha et al, (1995). Proc. Natl. Acad. Sci. USA 92: 1624-1628.) Use of nucleic acids of the invention to enhance gene expression Isolated sequences prepared as described herein can also be used to prepare expression cassettes which enhance or increase endogenous LECl gene expression. Where overexpression of a gene is desired, the desired gene from a different species may be used to decrease potential sense suppression effects. Enhanced expression of LECl polynucleotides is useful, for example, to increase storage protein content in plant tissues. Such techniques may be particularly useful for improving the nutritional value of plant tissues. One of skill will recognize that the polypeptides encoded by the genes of the invention, like other proteins, have different domains which perform different functions. Thus, the gene sequences need not be full length, so long as the desired functional domain of the protein is expressed. As explained above, LECl polypeptides share sequences with CBF proteins. The DNA binding activity, and, therefore, transcription activation function, of LECl polypeptides is thought to be modulated by a short region of seven residues (MPIANNI) at residues 34-40 of SEQ. ID No. 2. Thus, the polypeptides of the invention will often retain these sequences. Modified protein chains can also be readily designed utilizing various recombinant DNA techniques well known to those skilled in the art and described for instance, in Sambrook et al, supra. Hydroxylamine can also be used to introduce single base mutations into the coding region of the gene (Sikorski, et al, (1991). Meth. Enzymol 194: 302-318). For example, the chains can vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain. Desired modified LECl polypeptides can be identified using assays to screen for the presence or absence of wild type LECl activity. Such assays can be based on the ability of the LECl protein to functionally complement the hap3 mutation in yeast. As noted above, it has been shown that homologs from different species functionally interact with yeast subunits of the CBF. (Sinha, et al, (1995). Proc. Natl. Acad. Sci. USA 92: 1624-1628); see, also, Becker, et al, (1991). Proc. Nail Acad. Sci. USA 88: 1968-1972). The reporter for this screen can be any of a number of standard reporter genes such as the lacZ gene encoding β-galactosidase that is fused with the regulatory DNA sequences and promoter of the yeast CYC1 gene. This promoter is regulated by the yeast CBF. A plasmid containing the LECl cDNA clone is mutagenized in vitro according to techniques well known in the art. The cDNA inserts are excised from the plasmid and inserted into the cloning site of a yeast expression vector such as pYES2 (Invitrogen). The plasmid is introduced into hap3- yeast containing a lacZ reporter that is regulated by the yeast CBF such as pLG265UPl-lacZ (Guarente, el al, (1984) Cell 36: 317-321). Transformants are then selected and a filter assay is used to test colonies for β-galactosidase activity. After confirming the results of activity assays, immunochemical tests using a LECl antibody are performed on yeast lines that lack β-galactosidase activity to identify those that produce stable LECl protein but lack activity. The mutant LECl genes are then cloned from the yeast and their nucleotide sequence determined to identify the nature of the lesions. In other embodiments, the promoters derived from the LECl genes of the invention can be used to drive expression of heterologous genes in an embryo-specific or seed-specific manner, such that desired gene products are present in the embryo, seed, or fruit. Suitable structural genes that could be used for this purpose include genes encoding proteins useful in increasing the nutritional value of seed or fruit. Examples include genes encoding enzymes involved in the biosynthesis of antioxidants such as vitamin A, vitamin C, vitamin E and melatonin. Other suitable genes encoding proteins involved in modification of fatty acids, or in the biosynthesis of lipids, proteins, and carbohydrates. Still other genes can be those encoding proteins involved in auxin and auxin analog biosynthesis for increasing fruit size, genes encoding pharmaceutically useful compounds, and genes encoding plant resistance products to combat fungal or other infections of the seed. Typically, desired promoters are identified by analyzing the 5' sequences of a genomic clone corresponding to the embryo-specific genes described here. Sequences characteristic of promoter sequences can be used to identify the promoter. Sequences controlling eukaryotic gene expression have been extensively studied. For instance, promoter sequence elements include the TATA box consensus sequence (TATA AT), which is usually 20 to 30 base pairs upstream of the transcription start site. In most instances the TATA box is required for accurate transcription initiation. In plants, further upstream from the TATA box, at positions -80 to -100, there is typically a promoter element with a series of adenines surrounding the trinucleotide G (or T) N G. J. Messing et al. , in Genetic Engineering in Plants, pp. 221-227 (Kosage, Meredith and Hollaender, eds. (1983)). A number of methods are known to those of skill in the art for identifying and characterizing promoter regions in plant genomic DNA {see, e.g., Jordano, et al, Plant Cell, 1 : 855-866 (1989); Bustos, et al, Plant Cell, 1 :839-854 (1989); Green, et al, EMBO J. 7, 4035-4044 (1988); Meier, et al, Plant Cell, 3, 309-316 (1991); and Zhang, et al, Plant Physiology MO: 1069-1079 (1996)). Preparation of recombinant vectors To use isolated sequences in the above techniques, recombinant DNA vectors suitable for transformation of plant cells are prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the technical and scientific literature. See, for example, Weising et al. Ann. Rev. Genet. 22:421-477 (1988). A DNA sequence coding for the desired polypeptide, for example a cDNA sequence encoding a full length protein, will preferably be combined with transcriptional and translational initiation regulatory sequences which will direct the transcription of the sequence from the gene in the intended tissues of the transformed plant. For example, for overexpression, a plant promoter fragment may be employed which will direct expression of the gene in all tissues of a regenerated plant. Such promoters are referred to herein as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region, the 1 '- or 2'- promoter derived from T-DNA of Agrobacterium tumafaciens, and other transcription initiation regions from various plant genes known to those of skill. Alternatively, the plant promoter may direct expression of the polynucleotide of the invention in a specific tissue (tissue-specific promoters) or may be otherwise under more precise environmental control (inducible promoters). Examples of tissue-specific promoters under developmental control include promoters that initiate transcription only in certain tissues, such as fruit, seeds, or flowers. As noted above, the promoters from the LECl genes described here are particularly useful for directing gene expression so that a desired gene product is located in embryos or seeds. Other suitable promoters include those from genes encoding storage proteins or the lipid body membrane protein, oleosin. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobic conditions, elevated temperature, or the presence of light. If proper polypeptide expression is desired, a polyadenylation region at the 3 '-end of the coding region should be included. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The vector comprising the sequences {e.g. , promoters or coding regions) from genes of the invention will typically comprise a marker gene which confers a selectable phenotype on plant cells. For example, the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418, bleomycin, hygromycin, or herbicide resistance, such as resistance to chlorosluforon or Basta. Production of transgenic plants DNA constructs of the invention may be introduced into the genome of the desired plant host by a variety of conventional techniques. For example, the DNA construct may be introduced directly into the genomic DNA of the plant cell using techniques such as electroporation and microinjection of plant cell protoplasts, or the DNA constructs can be introduced directly to plant tissue using ballistic methods, such as DNA particle bombardment. Alternatively, the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector. The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria. Microinjection techniques are known in the art and well described in the scientific and patent literature. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski et al. Embo J. 3:2717-2722 (1984). Electroporation techniques are described in Fromm et al. Proc. Natl. Acad. Sci. USA 82:5824 (1985). Ballistic transformation techniques are described in Klein et al. Nature 327:70-73 (1987). Agrobacterium tumefaciens '-mediated transformation techniques, including disarming and use of binary vectors, are well described in the scientific literature. See, for example Horsch et al. Science 233:496-498 (1984), and Fraley et al. Proc. Natl. Acad. Sci. USA 80:4803 (1983). Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired phenotype such as seedlessness. Such regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the desired nucleotide sequences. Plant regeneration from cultured protoplasts is described in Evans et al. , Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts , pp. 21-73, CRC Press, Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee et al. Ann. Rev. of Plant Phys. 38:467-486 (1987). The nucleic acids of the invention can be used to confer desired traits on essentially any plant. Thus, the invention has use over a broad range of plants, including species from the genera Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Cucumis, Cucurbita, Daucus, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Oryza, Panieum, Pannesetum, Persea, Pisum, Pyrus, Prunus, Raphanus, Secale, Senecio, Sinapis, Solanum, Sorghum, Trigonella, Triticum, Vitis, Vigna, and, Zea. The LECl genes of the invention are particularly useful in the production of transgenic plants in the genus Brassica. Examples include broccoli, cauliflower, brussel sprouts, canola, and the like. One of skill will recognize that after the expression cassette is stably incorporated in transgenic plants and confirmed to be operable, it can be introduced into other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed. Example 1 This example describes the isolation and characterization of an exemplary LECl gene. Experimental Procedures Plant Material A lecl-2 mutant was identified from a population of Arabidopsis thaliana ecotype Wassilewskija (Ws-O) lines mutagenized with T-DNA insertions as described before (West et al., 1994). The abi3-3, fus3-3 and lecl-1 mutants were generously provided by Peter McCourt, University of Toronto and David Meinke, Oklahoma State University. Wild type plants and mutants were grown under constant light at 22°C. Double mutants were constructed by intercrossing the mutant lines lecl-1, lecl-2, abi3-3, fus3-3, and lec2. The genotype of the double mutants was verified through backcrosses with each parental line Double mutants were those who failed to complement both parent lines Homozygous single and double mutants were generated by germinating intact seeds or dissected mature embryos before desiccation on basal media Isolation and Sequence analysis of Genomic and cDNA Clones Genomic libraries of Ws-O wild type plants, lecl-1 and lecl-2 mutants were made in GEM11 vector according to the instructions of the manufacturer (Promega) Two silique-specific cDNA libraries (stages globular to heart and heart to young torpedo) were made in ZAPII vector (Stratagene) The genomic library of lecl-2 was screened using right and left T-DNA specific probes according to standard techniques About 12 clones that cosegragate with the mutation, were isolated and purified and the entire DNAs were further labeled and used as probes to screen a southern blot containing wild type and lecl-1 genomic DNA One clone hybridized with plant DNA and was further analyzed A 7 1 kb Xhol fragment containing the left border and the plant sequence flanking the T-DNA was subcloned into pBluescript-KS plasmid (Stratagene) to form ML7 and sequenced using a left border specific primer (5' GCATAGATGCACTCGAAATCAGCC 3') The T-DNA organization was partially verified using southern analysis with T-DNA left and right borders and PBR322 probes The results suggested that the other end of the T-DNA is also composed of left border This was confirmed by generating a PCR fragment using a genomic plant DNA primer (LP primer5' GCT CTA GAC ATA CAA CAC TTT TCC TTA 3') and a T-DNA left border specific primer (5' GCTTGGTAATAATTGTCATTAG 3') and sequencing The EcoRI insert of ML7 was used to screen a wild type genomic library Two overlapping clones were purified and a 7 4 EcoRI genomic fragment from the wild type DNA region was subcloned into pBluescript-KS plasmid making WT74 This fragment was sequenced (SEQ ID No 4) and was used to screen lecl-1 genomic library and wild type silique-specific cDNA libraries 8 clones from the lecl-1 genomic library were identified and analyzed by restriction mapping From these clones the exact site of the deletion in lecl-1 was mapped and sequenced by amplifying a Xbp PCR fragment using primers (H21 - 5' H21 - 5' CTA AAA ACA TCT ACG GTT CA 3', H 17 - 5' TTT GTG GTT GAC CGT TTG GC 3') flanking the deletion region in lecl-1 genomic DNA Clones were isolated from both cDNA libraries and partially sequenced The sequence of the cDNA clones and the wild type genomic clone matched exactly, confirming that both derived from the same locus All hybridizations were performed under stringent conditions with 32P random prime probes (Stratagene) Sequencing was done using the automated dideoxy chain termination method (Applied Biosystems, Foster City, CA) Data base searches were performed at the National Center for Biotechnology Information by using the BLAST network service Alignment of protein sequences was done using PILEUP program (Genetics Computer Group, Madison, WI) DNA and RNA blot analysis Genomic DNA was isolated from leaves by using the CTAB-containing buffer Dellaporta, et α/., (1983) Plant Mol. Biol. Reporter 1 19-21 Two micrograms of DNA was digested with different restriction endonucleases, electrophoretically separated in 1% agarose gel, and transferred to a nylon membrane (Hybond N, Amersham) Total RNA was prepared from siliques, two days old seedlings, stems, leaves, buds and roots Poly(A)+ RNA was purified from total RNA by oligo(dT) cellulose chromatography, and two micrograms of each Poly(A)+ RNA samples were separated in 1% denatured formaldehyde-agarose gel Hybridizations were done under stringent conditions unless it specifies otherwise Radioactive probes were prepared as described above Complementation of lee 1 mutants A 3 4 kb Bstyl fragment of genomic DNA (SEQ ID No 3) containing sequences from 1 992 kb upstream of the ORF to a region 579 bp downstream from the poly A site was subcloned into the hygromycin resistant binary vector pBIB-Hyg The LECl cDNA was placed under the control of the 35S promoter and the ocs polyadenylation signals by inserting a PCR fragment spanning the entire coding region into the plasmid pART7 The entire regulatory fragment was then removed by digestion with NotI and transferred into the hygromycin resistant binary vector BJ49 The binary vectors were introduced into the Agrobacterium strain GV3101, and constructions were checked by re-isolation of the plasmids and restriction enzyme mapping, or by PCR Transformation to homozygous lecl-1 and lecl-2 mutants were done using the in planta transformation procedure (Bechtold, et al , (1993) Comptes Rendus de VAcademie des Sciences Serie III Sciences de la Vie, 316 1194-1199 Dry seeds from leel mutants were selected for transformants by their ability to germinate after desiccation on plates containing 5g/ml hygromycin The transformed plants were tested for the present of the transgene by PCR and by screening the siliques for the present of viable seeds. In Situ Hybridization Experiments were performed as described previously by Dietrich et al. (1989) Plant Cell 1 : 73-80. Sections were hybridized with LECl antisense probe. As a negative control, the LECl antisense probe was hybridized to seed sections of lee 1 mutants. In addition, a sense probe was prepared and reacted with the wild type seed sections. Results Genetic Interaction Between Leafy Cotyledon-Type Mutants and abi3 In order to understand the genetic pathways which regulate late embryogenesis we took advantage of three Arabidopsis mutants lec2, fus3-3 and abi3-3 that cause similar defects in late embryogenesis to those of lecl-1 or lecl-2. These mutants are desiccation intolerant, sometimes viviparous and have activated shoot apical meristems. The lec2 and fus3-3 mutants are sensitive to ABA and possess trichomes on their cotyledons and therefore can be categorized as leafy cotyledon-type mutants (Meinke et al., 1994). The abi3-3 mutants belong to a different class of late embryo defective mutations that is insensitive to ABA and does not have trichomes on the cotyledons. The two classes of mutants were crossed to lecl-1 and lecl-2 mutants to construct plants homozygous to both mutations. The led and lec2 mutations interact synergistically, resulting in a double mutant which is arrested in a stage similar to the late heart stage, the double mutant embryo, however, is larger. The led or lec2 mάfus3-3 double mutants did not display any epistasis and the resulting embryo had an intermediate phenotype. The lecl/abi3-3 double mutants and lec2/abi3-3 double mutants were ABA insensitive and had a lec-like phenotype. There was no different between double mutants that consist of either lecl-1 or lecl-2. No epistasis was seen between the double mutants indicating that each of the above genes, the LEC-type and ABB genes, operate in different genetic pathways. LECl Functions Early in Embryogenesis The effects of lee 1 is not limited to late embryogenesis, it also has a role in early embryogenesis. The embryos of the lecl/lec2 double mutants were arrested in the early stages of development, while the single mutants developed into mature embryos, suggesting that these genes act early during development Further examination of the early stages of the single and double mutations showed defects in the shape, size and cell division pattern of the mutants suspensors The suspensor of wild type embryo consists of a single file of six to eight cells, whereas the suspensors of the mutants are often enlarged and undergo periclinal divisions Leafy cotyledon mutants exhibit suspensor anomalies at the globular or transition stage whereas wild type and abi3 mutant do not show any abnormalities The number of anomalous suspensors increases as the embryos continue to develop At the torpedo stage, the wild type suspensor cells undergo programmed cell death, but in the mutants secondary embryos often develop from the abnormal suspensors and, when rescued, give rise to twins The Organization of the LECl Locus in Wild Type Plants and led Mutants Two mutant alleles of the LECl gene have been reported, lecl-1 and lecl-2 (Meinke, 1992, West et al , 1994) Both mutants were derived from a population of plants mutagenized insertionally with T-DNA (Feldmann and Marks, 1987), although lecl-1 is not tagged The lecl-2 mutant contains multiple T-DNA insertions A specific subset of T-DNA fragments were found to be closely linked with the mutation A genomic library of lee 1-2 was screened using right and left borders T-DNA as probes Genomic clones containing T-DNA fragments that cosegragate with the mutation were isolated and tested on southern blots of both wild type and lecl-1 plants Only one clone hybridized with Arabidopsis DNA and also gave polymorphic restriction fragment in lecl-1 The lecl-1 polymorphism resulted from a small deletion, approximately 2 kb in length Using sequences from the plant fragment flanking the T-DNA, the genomic wild type DNA clones and the lecl-1 genomic clones were isolated An EcoRI fragment of 7 4 kb of the genomic wild type DNA that corresponded to the polymorphic restriction fragment in lecl-1 was further analyzed and sequenced The exact site of the deletion in lecl-1 was identified using a PCR fragment that was generated by primers, within the expected borders of the deleted fragment, and sequencing In the wild type genomic DNA that corresponded to the lecl-1 deletion, a 626 bp ORF was identified Southern analysis of wild type DNA and the two mutants DNA probed with the short DNA fragment of the ORF revealed that both the wild type and lecl-2 DNA contain the ORF while the lecl-1 genomic DNA did not hybridize The exact insertion site of the T-DNA in lecl-2 mutant was determined by PCR and sequencing and it was found that the T-DNA was inserted 115 bp upstream of the ORF's translational initiation codon in the 5' region of the gene At the site of the T-DNA insertion a small deletion of 21 plant nucleic acids and addition of 20 unknown nucleic acids occurred These results suggest that in lecl-2 the T-DNA interferes with the regulation of the ORF while in lecl-1 the whole gene is deleted Thus, both led alleles contain DNA disruptions at the same locus, confirming the identity of the LECl locus. The led Mutants Can Be Complement by Transformation To prove that the 7 4 kb genomic wild type fragment indeed contained the ORF of the LECl gene, we used a genomic fragment of 3395 bp (SEQ ID No. 3) within that fragment to transform homozygous lecl-1 and lecl-2 plants The clone consists of a 3395 bp BstYI restriction fragment containing the gene and the promoter region The translation start codon (ATG) of the polypeptide is at 1999 and the stop codon is at 2625 (TGA) There are no introns in the gene The transformed plants were selected on hygromycin plates and were tested to contain the wild type DNA fragment by PCR analysis Both transgenic mutants were able to produce viable progeny, that were desiccation tolerant and did not posses trichomes on their cotyledons We concluded that the 3 4 kb fragment can complement the lecl mutation and since there is only one ORF in the deleted 2 kb fragment in lecl-1 we suggest that this ORF corresponds to the LECl gene The LECl Gene is a Member of Gene Family In order to isolate the LECl gene two cDNA libraries of young siliques were screened using the 7 4 kb DNA fragment as a probe Seventeen clones were isolated and after further analysis and partial sequencing they were all found to be identical to the genomic ORF The cDNA contains 626 bp ORF specifying 208 amino acid protein (SEQ ID Nos 1 and 2) The LECl cDNA was used to hybridize a DNA gel blot containing Ws-0 genomic DNA digested with three different restriction enzymes Using low stringency hybridization we found that there is at least one more gene This confirmed our finding of two more Arabidopsis ESTs that show homology to the LECl gene The LECl gene is Embryo Specific The lecl mutants are affected mostly during embryogenesis. Rescued mutants can give rise to homozygous plants that have no obvious abnormalities other than the presence of trichomes on their cotyledons and their production of defective progeny. Therefore, we expected the LECl gene to have a role mainly during embryogenesis and not during vegetative growth. To test this assumption Poly (A)+ RNA was isolated from siliques, seedling, roots, leaves, stems and buds of wild type plants and from siliques of lecl plants. Only one band was detected on northern blots using either the LECl gene as a probe or the 7.4 kb genomic DNA fragment suggesting that there is only one gene in the genomic DNA fragment which is active transcriptionally. The transcript was detected only in siliques containing young and mature embryos and was not detected in seedlings, roots, leaves, stems and buds indicating that the LECl gene is indeed embryo specific. In addition, no RNA was detected in siliques of both alleles of lecl mutants confirming that this ORF corresponds to the LECl gene. Expression Pattern of the LECl Gene To study how the LECl gene specifies cotyledons identity, we analyzed its expression by in situ hybridization. We specifically focused on young developing embryos since the mutants abnormal suspensors phenotype indicates that the LECl gene should be active very early during development. During embryogenesis, the LECl transcript was first detected in proglobular embryos. The transcript was found in all cells of the proembryo and was also found in the suspensor and the endosperm. However, from the globular stage and on it accumulates more in the outer layer of the embryo, namely the protoderm and in the outer part of the ground meristem leaving the procambium without a signal. At the torpedo stage the signal was stronger in the cotyledons and the root meristem, and was more limited to the protoderm layer. At the bent cotyledon stage the signal was present throughout the embryo and at the last stage of development when the embryo is mature and filling the whole seed we could not detect the LECl transcript. This might be due to sensitivity limitation and may imply that if the LECl transcript is expressed at that stage it is not localized in the mature embryo, but rather spread throughout the embryo. The LECl gene encodes a Homolog of CCAAT binding factor. Comparison of the deduced amino acid sequence of LECl to the GeneBank reveals significant similarity to a subunit of a transcription factor, the CCAAT box binding factor (CBF). CBFs are highly conserved family of transcription factors that regulate gene activity in eukaryotic organisms Mantvani, et a , . (1992). Nucl. Acids Res. 20: 1087-1091. They are hetero-oligomeric proteins that consist of between three to four non-homologous subunits. LECl was found to have high similarity to CBF-A subunit. This subunit has three domains; A and C which show no conservation between kingdoms and a central domain, B, which is highly conserved evolutionary. Similarly the LECl gene is composed of three domains. The LECl B domain shares between 75%-85% similarity and 55%-63% identity with different B domains that are found in organisms ranging from yeast to human. Within this central domain, two highly conserved amino acid segments are present. Deletion and mutagenesis analysis in the CBF-A yeast homolog hap3 protein demonstrated that a short region of seven residues (42-48) (LPIANVA) is required for binding the CCAAT box, while the subunit interaction domain lies in the region between residues 69-80 ( MQECVSEFISFV) (Xing et al, supra). LECl protein shares high homology to those regions. DISCUSSION The lecl mutant belongs to the leafy cotyledon class that interferes mainly with the embryo program and therefore is thought to play a central regulatory role during embryo development. It was shown before that LECl gene activity is required to suppress germination during the maturation stage. Therefore, we analyzed the genetic interaction of homozygous double mutants of the different members of the leafy cotyledon class and the abi3 mutant that has an important role during embryo maturation. All the five different combinations of the double mutants showed either an intermediate phenotype or an additive effect. No epistatic relationship among the four genes was found. These findings suggest that the different genes act in parallel genetic pathways. Of special interest was the double mutant lecl/lec2 that was arrested morphologically at the heart stage, but continued to grow in that shape. This double mutant phenotype indicates that both genes LECl and LEC2 are essential for early morphogenesis and their products may interact directly or indirectly in the young developing embryo. The Role of LECl in Embryogenesis One of the proteins that mediate CCAAT box function, is an heteromeric protein called CBF (also called NFY or CPl). CBF is a transcription activator that regulates constitutively expressed genes, but also participates in differential activation of developmental genes Wingender, E. (1993). Gene Regulation in Eukaryotes (New York: VCH Publishers). In mammalian cells, three subunits have been identified CBF-A, CBF-B and CBF-C and all of which are required for DNA binding. In yeast, the CBF homolog HAP activates the CYC1 and other genes involved in the mitochondrial electron transport Johnson, et al, Proteins. Annu. Rev. Biochem. 58, 799-840. (1989). HAP consists of four subunits hap2, hap3, hap4 and hap5. Only hap2, 3 and 5 are required for DNA binding. CBF-A, B and C show high similarity to the yeast hap3, 2 and 5, respectively. It was also reported that mammalian CBF-A and B can be functionally interchangeable with the corresponding yeast subunits (Sinha et al, supra.). The LECl gene encodes a protein that shows more then 75% similarity to the conserved region of CBF-A. CCAAT motifs are not common in plants' promoters and their role in transcription regulation is not clear. However, maize and Brassica homologs have been identified Search in the Arabidopsis GeneBank revealed several ESTs that show high similarity to CBF-A, B and C. Accession numbers of CBF-A (HAP3) homologs: H37368, H76589; CBF-B (HAP2) homologs: T20769; CBF-C (HAP5) homologs: T43909, T44300. These findings and the pleiotropic affects of LECl suggest that LECl is a member of a heteromeric complex that functions as a transcription factor. The model suggests that LECl acts as transcription activator to several sets of genes, which keep the embryonic program on and repress the germination process. Defective LECl expression partially shuts down the embryonic program and as a result the cotyledons lose their embryonic characteristics and the germination program is active in the embryo. Example 2 This example demonstrates that LECl is sufficient to induce embryonic pathways in transgenic plants. The phenotype of led mutants and the gene's expression pattern indicated that LECl functions specifically during embryogenesis. A LECl cDNA clone under the control of the cauliflower mosaic virus 35S promoter was transferred into lecl-1 mutant plants inplanta using standard methods as described above. Viable dry seeds were obtained from lecl-1 mutants transformed with the 35S/LEC1 construct. However, the transformation efficiency was only approximately 0.6% of that obtained normally. In several experiments, half the seeds that germinated (12/23) produced seedlings with an abnormal morphology. Unlike wild type seedlings, these 35S/LEC1 seedlings possessed cotyledons that remained fleshy and that failed to expand. Roots often did not extend or extended abnormally and sometimes greened. These seedlings occasionally produced a single pair of organs on the shoot apex at the position normally occupied by leaves. Unlike wild type leaves, these organs did not expand and did not possess trichomes. Morphologically, these leaf-like structures more closely resembled embryonic cotyledons than leaves. The other 35S/LEC1 seeds that remained viable after drying produced plants that grow vegetatively. The majority of these plants (7) flowered and produced 100% led mutant seeds. Amplification experiments confirmed that the seedlings contained the transgene, suggesting that the 35S/LEC1 gene was inactive in these T2 seeds. No vegetative abnormalities were observed in these plants with the exception that a few displayed defects in apical dominance. A few plants (2) were male sterile and did not produce progeny. One plant that produced progeny segregated 25% mutant Led " seeds that, when germinated before desiccation and grown to maturity, gave rise to 100% mutant seed, as expected for a single transgene locus. The other 75% of seeds contained embryos with either a wild type phenotype or a phenotype intermediate between led mutants and wild type. Only 25% of the dry seed from this plant germinated, and all seedlings resembled the embryo-like seedlings described above. Some seedlings continued to grow and displayed a striking phenotype. These 35S/LEC1 plants developed two types of structures on leaves. One type resembled embryonic cotyledons while the other looked like intact torpedo stage embryos. Thus, ectopic expression of LECl induces the morphogenesis phase of embryo development in vegetative cells. Because many 35S/LEC1 seedlings exhibited embryonic characteristics, the seedlings were analyzed for expression of genes specifically active in embryos. Cruciferin A storage protein mRNA accumulated throughout the 35S/LEC1 seedlings, including the leaflike structures. Proteins with sizes characteristic of 12S storage protein cruciferin accumulated in these transgenic seedlings. Thus, 35S/LEC1 seedings displaying an embryolike phenotype accumulated embryo-specific mRNAs and proteins. LECl mRNA accumulated to a high level in these 35S/LEC1 seedlings in a pattern similar to early stage embryos but not in wild type seedlings. LECl is therefore sufficient to alter the fate of vegetative cells by inducing embryonic programs of development. The ability of LECl to induce embryonic programs of development in vegetative cells establishes the gene as a central regulator of embryogenesis. LECl is sufficient to induce both the seed maturation pathway as indicated by the induction of storage protein genes in the 35S/LEC1 seedlings. The presence of ectopic embryos on leaf surfaces and cotyledons at the position of leaves also shows that LECl can activate the embryo morphogenesis pathway. Thus, LECl regulates both early and late embryonic processes. The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: The Regents of the University of California (ii) TITLE OF INVENTION: Leafy Cotyledonl Genes and Their Uses (iii) NUMBER OF SEQUENCES: 18 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Fulbright & Jawors i , LLP (B) STREET: 865 S. Figueroa Street, 29th Floor (C) CITY: Los Angeles (D) STATE: California (E) COUNTRY: USA (F) ZIP: 90017-2571 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Berliner, Robert (B) REGISTRATION NUMBER: 20,121 (C) REFERENCE/DOCKET NUMBER: 5555-470 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (213) 892-9200 (B) TELEFAX: (213) 680-4518 (2) INFORMATION FOR SEQ ID NO : 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 627 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 1..627 (D ) OTHER INFORMATION : /product= " LECl " ( xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 1 : ATG ACC AGC TCA GTC ATA GTA GCC GGC GCC GGT GAC AAG AAC AAT GGT 48 Met Thr Ser -Ser Val lie Val Ala Gly Ala Gly Asp Lys Asn Asn Gly 1 5 10 15 ATC GTG GTC CAG CAG CAA CCA CCA TGT GTG GCT CGT GAG CAA GAC CAA 96 lie Val Val Gin Gin Gin Pro Pro Cys Val Ala Arg Glu Gin Asp Gin 20 25 30 TAC ATG CCA ATC GCA AAC GTC ATA AGA ATC ATG CGT AAA ACC TTA CCG 144 Tyr Met Pro lie Ala Asn Val lie Arg lie Met Arg Lys Thr Leu Pro 35 40 45 TCT CAC GCC AAA ATC TCT GAC GAC GCC AAA GAA ACG ATT CAA GAA TGT 192 Ser His Ala Lys lie Ser Asp Asp Ala Lys Glu Thr lie Gin Glu Cys 50 55 60 GTC TCC GAG TAC ATC AGC TTC GTG ACC GGT GAA GCC AAC GAG CGT TGC 240 Val Ser Glu Tyr lie Ser Phe Val Thr Gly Glu Ala Asn Glu Arg Cys 65 70 75 80 CAA CGT GAG CAA CGT AAG ACC ATA ACT GCT GAA GAT ATC CTT TGG GCT 288 Gin Arg Glu Gin Arg Lys Thr lie Thr Ala Glu Asp lie Leu Trp Ala 85 90 95 ATG AGC AAG CTT GGG TTC GAT AAC TAC GTG GAC CCC CTC ACC GTG TTC 336 Met Ser Lys Leu Gly Phe Asp Asn Tyr Val Asp Pro Leu Thr Val Phe 100 105 110 ATT AAC CGG TAC CGT GAG ATA GAG ACC GAT CGT GGT TCT GCA CTT AGA 384 lie Asn Arg Tyr Arg Glu lie Glu Thr Asp Arg Gly Ser Ala Leu Arg 115 120 125 GGT GAG CCA CCG TCG TTG AGA CAA ACC TAT GGA GGA AAT GGT ATT GGG 432 Gly Glu Pro Pro Ser Leu Arg Gin Thr Tyr Gly Gly Asn Gly lie Gly 130 135 140 TTT CAC GGC CCA TCT CAT GGC CTA CCT CCT CCG GGT CCT TAT GGT TAT 480 Phe His Gly Pro Ser His Gly Leu Pro Pro Pro Gly Pro Tyr Gly Tyr 145 150 155 160 GGT ATG TTG GAC CAA TCC ATG GTT ATG GGA GGT GGT CGG TAC TAC CAA 528 Gly Met Leu Asp Gin Ser Met Val Met Gly Gly Gly Arg Tyr Tyr Gin 165 170 175 AAC GGG TCG TCG GGT CAA GAT GAA TCC AGT GTT GGT GGT GGC TCT TCG 576 Asn Gly Ser Ser Gly Gin Asp Glu Ser Ser Val Gly Gly Gly Ser Ser 180 185 190 TCT TCC ATT AAC GGA ATG CCG GCT TTT GAC CAT TAT GGT CAG TAT AAG 624 Ser Ser lie Asn Gly Met Pro Ala Phe Asp His Tyr Gly Gin Tyr Lys 195 200 205 TGA 627 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 208 amino acids (B) TYPE: amino acid . (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 2 : Met Thr Ser Ser Val lie Val Ala Gly Ala Gly Asp Lys Asn Asn Gly 1 5 10 15 lie Val Val Gin Gin Gin Pro Pro Cys Val Ala Arg Glu Gin Asp Gin 20 25 30 Tyr Met Pro lie Ala Asn Val lie Arg lie Met Arg Lys Thr Leu Pro 35 40 45 Ser His Ala Lys lie Ser Asp Asp Ala Lys Glu Thr lie Gin Glu Cys 50 55 60 Val Ser Glu Tyr lie Ser Phe Val Thr Gly Glu Ala Asn Glu Arg Cys 65 70 75 80 Gin Arg Glu Gin Arg Lys Thr He Thr Ala Glu Asp He Leu Trp Ala 85 90 95 Met Ser Lys Leu Gly Phe Asp Asn Tyr Val Asp Pro Leu Thr Val Phe 100 105 110 He Asn Arg Tyr Arg Glu He Glu Thr Asp Arg Gly Ser Ala Leu Arg 115 120 125 Gly Glu Pro Pro Ser Leu Arg Gin Thr Tyr Gly Gly Asn Gly He Gly 130 135 140 Phe His Gly Pro Ser His Gly Leu Pro Pro Pro Gly Pro Tyr Gly Tyr 145 150 155 160 Gly Met Leu Asp Gin Ser Met Val Met Gly Gly Gly Arg Tyr Tyr Gin 165 170 175 Asn Gly Ser Ser Gly Gin Asp Glu Ser Ser Val Gly Gly Gly Ser Ser 180 185 190 Ser Ser He Asn Gly Met Pro Ala Phe Asp His Tyr Gly Gin Tyr Lys 195 200 205 (2) INFORMATION FOR SEQ ID NO : 3 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3395 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 3 : AGATCCAAAA CAGGTCATGG ACTGGGCCGT AAACTCTATC CAAAATTCTT CATGTTTTTC 60 CATCTTTCAA AAATCTTTAT CCACCATTCC ATTACTAGGG TGTTGGTTTT ATTTTATTTG 120 TTGATTAATT ATGTATTAGA AAATGTAAAG CAATATTCAA TTGTAACATG CATCATCTAA 180 CACCAATATC TTGTACTAAC CTTTTGTAAT TTTCCTATAA ACATTTTAAA AGGCTAATTT 240 AAATAAAAAT TACAATAAAC GTGATAACTC ACTTTCGTAA CGCATATTTA TTCAAATATA 300 CCAAAATTTA CCATTTTAAG TAAGAGAATC TTTTTAAAAT TAATTTTCAA TTTCATTAAT 360 TAAGAAACAA AGAATTTACT GAAACCTATA TTTTATTAAA TTTTAATAAA ATATATGACT 420 AAAATAACGT CACGTGAATC TTTCTCAGCC GTTCGATAAT CGAATACTTT ATTGACTAAG 480 TATTTATTTA GAAAATTTTA AACAACACTT AATTTCTAGA AACAAAGAGA GCCTCATATG 540 TATAAAAATC TTCTTCTTAT CTTTCTTTCT TTCTTAATAG TCTTTATTTT TACTTAATTA 600 CTTTGGTAAT TTGTGAAAAA CACAACCAAT GAGAGAAGAG CAGTTTGACT GGCCACATAG 660 CCAATGAGAC AAGCCAATGG GAAAGAGATA TAGAGACCTC GTAAGAACCG CTCCTTTGCC 720 ATTTGTATCA TCTCTCTATA AAACCACTCA ACCATCAACC TNTCTTTGCA TGCAACAAAT 780 CACTCAAATA ATTATTTTAT AAAGAACAAA AAAAAAAAGA CGGCAGAGAA ACAATGGAAC 840 GTGGAGCTCC CTTCTCTCAC TATCAGCTAC CCAAATCCAT CTCTGGTAAT CTAAGTGGCT 900 ATTTGTATAC AGTATATACT TGCCTCCATG TATATTTATA TTCTCGTGAA AAATTGGAGA 960 CATGCTTTAT GAATTTTATG AGACTTTGCA ACAACGAACG AGATGCTTTC TCTCTAGAAA 1020 TTTAAATTTA GATTTGTGAA GGTTTTGGGA ATGGCCCGGA GAAGACGATT TTATATATAC 1080 ATGCATGCAA GAGTTTGATA TGTATATTGT TTCATCATGG CTGAGTCAAA GTTTTATCCA 1140 AATATTTCCA TGGTGTGGTA TTAGTTAAAC AAATCTCTCG TATGTGTC T TGAATATACC 1200 CGTGCATGTA CCAGGAATGT TTTTGATTCT AAAAACGTTT TTTTCTTTGT TGTAACGGTT 1260 GAGTTTTTTT CTTCGTTTCA AAACGAGATT CTCGTTTGTC TCTTCCCTTG TCTAAAAACA 1320 TCTACGGTTC ATGTGATTCA AAAACACTAA AAAAATATAA ACTCATTTTT TTTTAATACT 1380 TAACATTTAA ACTATATATA TATATATATA TATATATATC TTATACTAGT CCCAAGTTTT 1440 AGTGTGAGGT TTTTTTATTC AAAATCTATC AGTACATTTT TTGGAAAAGA ACTAAGTGAA 1500 ATTTTCTCCA AATTTTCCTT TTACTATTGA TTTTTTAATT ACTGGATGTC ATTAACTTTA 1560 ATCTTTTGAT TCTTTCAACG TTTACCATTG GGAACCTTCA CATGAAATAA ATGTCTACTT 1620 TATTGAGTCA TACCTTCGTC AACATAAATT AATTGATGTT CTTCTCCAAA TTTTGAGTTT 1680 TTGGTTTTTC TAATAATCTT AACGAAAGCT TTTTGGTATA CATGTAAAAC GTAACGGCAA 1740 GAATCTGAAC AGTCTACTCA ACGGGGTCCA TAAGTCTAGA ATGTAGACCC CACAAACTTA 1800 CTCTTATCTT ATTGGTCCGT AACTAAGAAC GTGTCCCTCT GATTCTCTTG TTTTCTTCTA 1860 ATTAATTCGT ATCCTACAAA TTTAATTATC ATTTCTACTT CAACTAATCT TTTTTTATTT 1920 CCTAAAGATT TCAATTTCTC TCTGTATTTT CTATGAACAG AATTGAACTT GGACCAGCAC 1980 AGCAACAACC CAACCCCAAT GACCAGCTCA GTCATAGTAG CCGGCGCCGG TGACAAGAAC 2040 AATGGTATCG TGGTCCAGCA GCAACCACCA TGTGTGGCTC GTGAGCAAGA CCAATACATG 2100 CCAATCGCAA ACGTCATAAG AATCATGCGT AAAACCTTAC CGTCTCACGC CAAAATCTCT 2160 GACGACGCCA AAGAAACGAT TCAAGAATGT GTCTCCGAGT ACATCAGCTT CGTGACCGGT 2220 GAAGCCAACG AGCGTTGCCA ACGTGAGCAA CGTAAGACCA TAACTGCTGA AGATATCCTT 2280 TGGGCTATGA GCAAGCTTGG GTTCGATAAC TACGTGGACC CCCTCACCGT GTTCATTAAC 2340 CGGTACCGTG AGATAGAGAC CGATCGTGGT TCTGCACTTA GAGGTGAGCC ACCGTCGTTG 2400 AGACAAACCT ATGGAGGAAA TGGTATTGGG TTTCACGGCC CATCTCATGG CCTACCTCCT 2460 CCGGGTCCTT ATGGTTATGG TATGTTGGAC CAATCCATGG TTATGGGAGG TGGTCGGTAC 2520 TACCAAAACG GGTCGTCGGG TCAAGATGAA TCCAGTGTTG GTGGTGGCTC TTCGTCTTCC 2580 ATTAACGGAA TGCCGGCTTT TGACCATTAT GGTCAGTATA AGTGAAGAAG GAGTTATTCT 2640 TCATTTTTAT ATCTATTCAA AACATGTGTT TCGATAGATA TTTTATTTTT ATGTCTTATC 2700 AATAACATTT CTATATAATG TTGCTTCTTT AAGGAAAAGT GTTGTATGTC AATACTTTAT 2760 GAGAAACTGA TTTATATATG CAAATGATTG AATCCAAACT GTTTTGTGGA TTAAACTCTA 2820 TGCAACATTA TATATTTACA TGATCTAAAG GTTTTGTAAT TCAAAAGCTG TCATAGTTAG 2880 AAGATAACTA AACATTGTAG TAACCAAGTT TAATTTACTT TTTTGAGTTT ACATAACTAA 2940 CCAAGCCAAA AGGTTATAAA ATCTAAATTC GTTGAGTTGT CAAACTTCTG AAGATTGCTA 3000 TCCTCTTTGA GTTGCTTTCT TTTGGGTGCT TGAGTTTCAT TAGGCTGAGC TGACTCGTTG 3060 CTCTCTAGTC TTTCATCTCT GTCTTTTCCA AGGATTCATA ACGTTGGTCG CTCTCTGTTT 3120 CTGCCTACAC TTCTTCAAGG GATCATTACT GAGGCTAAGA GTTAAAGACC TGAACCATGG 3180 TTTTCTGTAA CTGGTTCAAG TTCATTCTCC GGTTATTGTG TGGTTATCTT TCGGTTAGAT 3240 TGAAACCCAT ATGTTTGCTC TGTTTCTTCT AGTTCCAAGT TTAATTTCCG GTTATTGTTT 3300 GGCTTTTTAA AAGTTTTTAA GGTCTATTCT ATGTAAAGAC TATTCTACGT ACGTACATTT 3360 ATCGCAAAAT TGAAAGATTA TAAAAAAAAT TGAAA 3395 (2) INFORMATION FOR SEQ ID NO : 4 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7560 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 4 : AATTNACCCT CACTAAAGGG AACAAAAGCT GGGTACCGGG CCCCCCCTCG AGGTCGACGG 60 TATCGATAAG CTTGATATCG AATTCGTGGC CATTAGACCC ATAACTATAT GACGATGTTA 120 AAGAGAAAAT AAATCATAAA TAAAATAAGA GTCCTTATCA ATAAACCTAA TTGGCTAATT 180 TCAACCTCAA AGAGTAGTAG GAACAGGTAA GGTGAAGCCA AACAGCTCCT TTTACAGTTG 240 GACCACTAGA GCTGATCTGG CATACAAAGT ATGCTTATTG GGCTGTCACG GCCCATCCGC 300 AAAATGTCGT TGGTTACGAA GCATCCACGA CATAGACGGT GCCACATGTT AGAAAAGTGT 360 TTCGGCGATC AAGATTGTGT CCACATCATT AGACGTCTGA ACTGTCCACG TGTCTATCAA 420 AGCTGGCGTC AAACATTACG TTTTCGTCGT TTGCGCCTCC TAGTTCACAC GTGCAACGAA 480 CGCGTGCGAC GTATCAAAAT TGTTAATTTT AGCCATGTAT AAAGAATATC TACAAAATTA 540 ACCTCAGGAA TATTTTTGTT TTTTCAATTG AGGCCATAAT ATACNTNCCG ATNGAAAAAT 600 TTTNCANCAT ATCNCTAATA TCAAAAAATT ATGATGTTAG TAAACGTAAA AAATTTACAC 660 AAAATAANTT TCACAAAACT TANNGGGGAA ATTGGAACAA ANAAAAGACT GGTGAGTGAT 720 AAGCGATGAT GGCCGGTGAA TCAGGTAGCC GTCCTACAAC GTGGTTGATT TTGAGCAAAC 780 TCCTATCTAC TCTTCACACT ATTGGAAATC CCAAAATGTC GTCACACCAT AATAATGTGA 840 ATTTTGTTAT GGAATTTGAG GGAAACAGTA GATATATGTT TCAACCAGTG AAAGTTACCC 900 TCCTTTGGAC ATATCTACGA NAGTAGAAAG TAGAAACATT CACTAAACGT GACAACTTTA 960 TAAATTTTCT TTTTGTAACT TTTCTTTAGA TTTATTTACG ANAAGAGAAA TATAAACGTC 1020 ATGCTAATAA AAAATGCATT ATTTTCTACC ATCTAGCTAG AATATTGATC AAGTCTTCAC 1080 GTTTTTTGTT TATCTCTTCT CTCATAGGCA TGTCCACAAA AGGGTAAGTT TTACTGGTTC 1140 AAAATATTGC ATGAGTACTA CTAAGCTCGT ATAGTTTGAT CTTACTATCA TTGCGATGAG 1200 GGTTGTTAGT TTGGAAGAAA TAAGGATTTA TGCAAATGGT AATCATTATG TCTGCTATTT 1260 AAGAAGTAAA TTATGATGCT TGTTGCGTGA ACATATTAAA TTTGCGAAAA ATAAGCAAGG 1320 ATACACGAGA GAAGCTCAGA TATTCACGTA ACGATGTTTC ATCTCTTCTC ATTGAGGAAA 1380 CATATGGCCA TGATATAGCT AATAAGCCTA CGGGATTGTC NTTTCAACGC CGAATCTACC 1440 AAACTGTTCC ATCTCTTATT ATATATAGTT TGGTTATTTA AGTAATTAGA TGCATCATAA 1500 TCTTTTTTTC TGCCAGTTGT AATGCAGATA AAAATATATT GGTTGTTCTA AGGATTGTTC 1560 AAACGTGCAT GTGTACAAGT TATTATTTAT ATACTTTCAT CTACATGCGA TGCGTTATTT 1620 ATAATGATAA AACTAAGATT TTTAGTTAAA TTTAATAAAG AGCTTACGAG CTACAATTAA 1680 TTAGAAATGG TTGCTCAGAA ATCAGAATAC TATATATGAA AAAAGAAGTT GGTATACTTG 1740 AAAAAAGAAA AAACTACTTG AAAAGATGGT AAAAGATATA GAACGAGTAT ATATCTTACT 1800 CAAGCACGAT AGAAGTTTGT ATCAAAACAT TGCGTTCCAA ACCAATGTTT GAAGATGGTC 1860 AAAGGTGCTA CTCATGATGT GGTGCGAAGA AGCTTACGAA AAATTCTGCA ATGAGAGATA 1920 ACTTTATGGG CTGCTTGTTC AATATATTGA AAATCATGGT AGACAACACC AAACTCTCCT 1980 TTACCAGAAG TCATATTTCC TTAACCTCAG AATAAGTAAA TCTTCTAGTT TATTATTTGA 2040 AAGTTGAGCG TATAATTGCA ATGAAACTTT TACCAATTCA CCGCCTCCTA ACTGAGTTGT 2100 TGTATTATCC TATCTCTTTA GCTATCCTTT CCTTGCTCTT GCTCCACCTG CATGTGGCCT 2160 CTTTATTTAT AATCTCTCTA GATTCTGCTA AAGATGTNTG TTCAAAATGG TTTATCTTTA 2220 AGGGAAGCAA AGTGAATGGA AACATTTAAA GAAAAAAAAA ACTTTTAGCA GAGTTCCATG 2280 AGATTTCATA CTGATGATAA CTAAAATAAT CTTATATGCG TAAGATTATT TTAGTTCTAA 2340 ACTTCATTTT GAAATGAGAG GTCATTGGCC AGGAAAGATT CAATATTGGT TCTTTGTTAA 2400 TTCTCGTTGG TTTGTTTTTA GTATGGGCTA GATCCAAAAC AGGTCATGGA CTGGGCCGTA 2460 AACTCTATCC AAAATTCTTC ATGTTTTTCC ATCTTTCAAA AATCTTTATC CACCATTCCA 2520 TTACTAGGGT GTTGGTTTTA TTTTATTTGT TGATTAATTA TGTATTAGAA AATGTAAAGC 2580 AATATTCAAT TGTAACATGC ATCATCTAAC ACCAATATCT TGTACTAACC TTTTGTAATT 2640 TTCCTATAAA CATTTTAAAA GGCTAATTTA AATAAAAATT ACAATAAACG TGATAACTCA 2700 CTTTCGTAAC GCATATTTAT TCAAATATAC CAAAATTTAC CATTTTAAGT AAGAGAATCT 2760 TTTTAAAATT AATTTTCAAT TTCATTAATT AAGAAACAAA GAATTTACTG AAACCTATAT 2820 TTTATTAAAT TTTAATAAAA TATATGACTA AAATAACGTC ACGTGAATCT TTCTCAGCCG 2880 TTCGATAATC GAATACTTTA TTGA.CTAAGT ATTTATTTAG AAAATTTTAA ACAACACTTA 2940 ATTTCTAGAA ACAAAGAGAG CCTCATATGT ATAAAAATCT TCTTCTTATC TTTCTTTCTT 3000 TCTTAATAGT CTTTATTTTT ACTTAATTAC TTTGGTAATT TGTGAAAAAC ACAACCAATG 3060 AGAGAAGAGC AGTTTGACTG GCCACATAGC CAATGAGACA AGCCAATGGG AAAGAGATAT 3120 AGAGACCTCG .TAAGAACCGC TCCTTTGCCA TTTGTATCAT CTCTCTATAA AACCACTCAA 3180 CCATCAACCT NTCTTTGCAT GCAACAAATC ACTCAAATAA TTATTTTATA AAGAACAAAA 3240 AAAAAAAGAC GGCAGAGAAA CAATGGAACG TGGAGCTCCC TTCTCTCACT ATCAGCTACC 3300 CAAATCCATC TCTGGTAATC TAAGTGGCTA TTTGTATACA GTATATACTT GCCTCCATGT 3360 ATATTTATAT TCTCGTGAAA AATTGGAGAC ATGCTTTATG AATTTTATGA GACTTTGCAA 3420 CAACGAACGA GATGCTTTCT CTCTAGAAAT TTAAATTTAG ATTTGTGAAG GTTTTGGGAA 3480 TGGCCCGGAG AAGACGATTT TATATATACA TGCATGCAAG AGTTTGATAT GTATATTGTT 3540 TCATCATGGC TGAGTCAAAG TTTTATCCAA ATATTTCCAT GGTGTGGTAT TAGTTAAACA 3600 AATCTCTCGT ATGTGTCATT GAATATACCC GTGCATGTAC CAGGAATGTT TTTGATTCTA 3660 AAAACGTTTT TTTCTTTGTT GTAACGGTTG AGTTTTTTTC TTCGTTTCAA AACGAGATTC 3720 TCGTTTGTCT CTTCCCTTGT CTAAAAACAT CTACGGTTCA TGTGATTCAA AAACACTAAA 3780 AAAATATAAA CTCATTTTTT TTTAATACTT AACATTTAAA CTATATATAT ATATATATAT 3840 ATATATATCT TATACTAGTC CCAAGTTTTA GTGTGAGGTT TTTTTATTCA AAATCTATCA 3900 GTACATTTTT TGGAAAAGAA CTAAGTGAAA TTTTCTCCAA ATTTTCCTTT TACTATTGAT 3960 TTTTTAATTA CTGGATGTCA TTAACTTTAA TCTTTTGATT CTTTCAACGT TTACCATTGG 4020 GAACCTTCAC ATGAAATAAA TGTCTACTTT ATTGAGTCAT ACCTTCGTCA ACATAAATTA 4080 ATTGATGTTC TTCTCCAAAT TTTGAGTTTT TGGTTTTTCT AATAATCTTA ACGAAAGCTT 4140 TTTGGTATAC ATGTAAAACG TAACGGCAAG AATCTGAACA GTCTACTCAA CGGGGTCCAT 4200 AAGTCTAGAA TGTAGACCCC ACAAACTTAC TCTTATCTTA TTGGTCCGTA ACTAAGAACG 4260 TGTCCCTCTG ATTCTCTTGT TTTCTTCTAA TTAATTCGTA TCCTACAAAT TTAATTATCA 4320 TTTCTACTTC AACTAATCTT TTTTTATTTC CTAAAGATTT CAATTTCTCT CTGTATTTTC 4380 TATGAACAGA ATTGAACTTG GACCAGCACA GCAACAACCC AACCCCAATG ACCAGCTCAG 4440 TCATAGTAGC CGGCGCCGGT GACAAGAACA ATGGTATCGT GGTCCAGCAG CAACCACCAT 4500 GTGTGGCTCG TGAGCAAGAC CAATACATGC CAATCGCAAA CGTCATAAGA ATCATGCGTA 4560 AAACCTTACC GTCTCACGCC AAAATCTCTG ACGACGCCAA AGAAACGATT CAAGAATGTG 4620 TCTCCGAGTA CATCAGCTTC GTGACCGGTG AAGCCAACGA GCGTTGCCAA CGTGAGCAAC 4680 GTAAGACCAT AACTGCTGAA GATATCCTTT GGGCTATGAG CAAGCTTGGG TTCGATAACT 4740 ACGTGGACCC CCTCACCGTG TTCATTAACC GGTACCGTGA GATAGAGACC GATCGTGGTT 4800 CTGCACTTAG AGGTGAGCCA CCGTCGTTGA GACAAACCTA TGGAGGAAAT GGTATTGGGT 4860 TTCACGGCCC ATCTCATGGC CTACCTCCTC CGGGTCCTTA TGGTTATGGT ATGTTGGACC 4920 AATCCATGGT TATGGGAGGT GGTCGGTACT ACCAAAACGG GTCGTCGGGT CAAGATGAAT 4980 CCAGTGTTGG TGGTGGCTCT TCGTCTTCCA TTAACGGAAT GCCGGCTTTT GACCATTATG 5040 GTCAGTATAA GTGAAGAAGG AGTTATTCTT CATTTTTATA TCTATTCAAA ACATGTGTTT 5100 CGATAGATAT TTTATTTTTA TGTCTTATCA ATAACATTTC TATATAATGT TGCTTCTTTA 5160 AGGAAAAGTG TTGTATGTCA ATACTTTATG AGAAACTGAT TTATATATGC AAATGATTGA 5220 ATCCAAACTG TTTTGTGGAT TAAACTCTAT GCAACATTAT ATATTTACAT GATCTAAAGG 5280 TTTTGTAATT CAAAAGCTGT CATAGTTAGA AGATAACTAA ACATTGTAGT AACCAAGTTT 5340 AATTTACTTT TTTGAGTTTA CATAACTAAC CAAGCCAAAA GGTTATAAAA TCTAAATTCG 5400 TTGAGTTGTC AAACTTCTGA AGATTGCTAT CCTCTTTGAG TTGCTTTCTT TTGGGTGCTT 5460 GAGTTTCATT AGGCTGAGCT GACTCGTTGC TCTCTAGTCT TTCATCTCTG TCTTTTCCAA 5520 GGATTCATAA CGTTGGTCGC TCTCTGTTTC TGCCTACACT TCTTCAAGGG ATCATTACTG 5580 AGGCTAAGAG TTAAAGACCT GAACCATGGT TTTCTGTAAC TGGTTCAAGT TCATTCTCCG 5640 GTTATTGTGT GGTTATCTTT CGGTTAGATT GAAACCCATA TGTTTGCTCT GTTTCTTCTA 5700 GTTCCAAGTT TAATTTCCGG TTATTGTTTG GCTTTTTAAA AGTTTTTAAG GTCTATTCTA 5760 TGTAAAGACT ATTCTACGTA CGTACATTTA TCGCAAAATT GAAAGATTAT AAAAAAAATT 5820 GAAAGATCCA AAGGAAACCA ATAGATTAAA CTAAAATGTA GTATCCTTTT TATCATTTTA 5880 GGCTATGTTT TCTTTTAAGA AAGCTTTGGT AGTTAACTCT GTTTAAAAGA AAAAAAAGAG 5940 ATGCATAAAT TAAATTTAAG TTTCTAGAAC TTTTGGATAA ACATATTAAG CTAAAGAAAT 6000 TAAACTAAAG GGCGTAAATG CAAGCTTGTT ATGCGTTATT GAAAACATTA CCTCTAAATT 6060 AAATAGCCCA ATATTGAAAA CCTTAAGCTT CTTTGATCCC CTTAACTTGT TTGTCCACCA 6120 AGTATTAGTT CATCTCTTAA CACGGCAACT CGAAACGGCA CAATGGACAA ACATGGTCTT 6180 TCAAAAACCA CTTCCCAATA CATCCATCGT CAAACTCGTG GCCACATGGT AAGGTCACCA 6240 CTATTTCTCC CTTTTCAAAC TCCTCCAAAC AAATTGTGCA CACACTGGCG TCAGAGTTGG 6300 ATTTCTTCTT ATTATTATAT ACTTTCCTTG CCAAACGGTC AACCACAAAC TTATTTGCCG 6360 GTCTAATTAA CTCGATATTA TTGGTGGTCT CATCAAACGA GTCAATCCGA GGAGGAGGTG 6420 GAACAATGAC TTTACAGTAC ATGTAAACTA ACGTAGCACA AACTGAAGAG TCTACCATAG 6480 AAATCGACTT ACAGATTCGT TCAGTGAGTT GAGAGTTAGC AATGTCAACA TATTGTTCGG 6540 AGAGCCCTGC TGAGTACAAC CATTCATTCA GTTTTTTCGA GTCATTAGGG TAGGAGGATA 6600 TGACACCTTC GTAGTCATTG TACGAGAGAA CGAAATTTGG TGGAAGACTA ATTGATGTGT 6660 CCGATCTTCG GGCACTTACG CAGATTTTGA ATGATCCAGC ATCTTGTGAT TTCGGTTTGA 6720 GGTCTATTTC GCCGCCAAAG GATATTTCCG CTTCCATAGC TATCAAAGAG AAAGAAAAAT 6780 AGTGAATCCA AGGTTTAGGG TTTCTTTTCT TTGTCTTNCT TATATATAGA GGCGCTAGAT 6840 TGTATTAAGG ATTATACATA TATATAAGTA ATTGCAATTT GTGAGTTTAT CCTTATTCAT 6900 TTTTAATTTT ATTTACCTTT ATTTAGTTGA TATTGTGTCC TTTTCCTAGG TAGCATTTCC 6960 TTCCATCTGT GTTAATTATT AGCATTTCCT TTCCTTTGTC TTATTTGCCT TTATTTCGTA 7020 GGAAGAAATC CTTTATGNAC CCCATCTTGG CTGAGAACTT GAGATGATTT TAAATCCTCA 7080 AAAATTATTC AATTTATGAT TTCGAAATTG ATATACACTT TATATTTTCT CCTAAAAAAC 7140 CATATTGTAC TAAGAAAAGT AGAAAACCAG ACTTTTTAAT ATGTTAGATT TTAATTGGGT 7200 TCTTAAAGTG TTTTAGCGTT TNACACCGGT TATTCTCCAA AATCCAAACT CTATAATTAT 7260 AGTTTTTAAG TATAAATTAA TCCGGTTGGC CCAATTAGTG GACCGTTTAA AGAGTAGACA 7320 CTTTTTTTTT TATATATCGA CTACCATAAA ACTTTAACGA TTAATATTTT TGGATAATAA 7380 GCGATCGTTT TGAGGCGTCC CAATTTTTTT TGTTTCTTTT TATATGAGAA ATGGGTTTAA 7440 GAAAAACTGC AATTTTGTCC ATAAAGCTAG TCAGAATTCC TGCAGCCCGG GGGATCCACT 7500 AGTTCTAGAG CGGCCGCCAC CGCGGTGGAG CTCCAATTCG CCCTATAGTG AGTCGTATTA 7560 (2) INFORMATION FOR SEQ ID NO : 5 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS : (D) TOPOLOGY: linear !ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 : Met Pro He Ala Asn Val He 1 5 (2) INFORMATION FOR SEQ ID NO : 6 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear [ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 6 : He Gin Glu Cys Val Ser Glu Tyr He Ser Phe Val 1 5 10 (2) INFORMATION FOR SEQ ID NO : 7 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7 : GGAATTCAGC AACAACCCAA CCCCA 25 (2) INFORMATION FOR SEQ ID NO : 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 8 : GCTCTAGACA TACAACACTT TTCCTTA 27 (2) INFORMATION FOR SEQ ID NO : 9 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 : ATGACCAGCT CAGTCATAGT AGC 23 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: GCCACACATG GTGGTTGCTG CTG 23 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: GAGATAGAGA CCGATCGTGG TTC 23 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: TCACTTATAC TGACCATAAT GGTC 24 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: GCATAGATGC ACTCGAAATC AGCC 24 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: GCTTGGTAAT AATTGTCATT AG 22 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 15 : CTAAAAACAT CTACGGTTCA 20 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: TTTGTGGTTG ACCGTTTGGC 20 (2) INFORMATION FOR SEQ ID NO : 17 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: Leu Pro He Ala Asn Val Ala 1 5 (2) INFORMATION FOR SEQ ID NO -.18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: Met Gin Glu Cys Val Ser Glu Phe He Ser Phe Val 1 5 10

Claims: WHAT IS CLAIMED IS 1 An isolated nucleic acid molecule comprising a LECl polynucleotide sequence, which polynucleotide sequence specifically hybridizes to SEQ ID No 1 under stringent conditions 2 The isolated nucleic acid molecule of claim 1 , wherein the LECl polynucleotide is between about 100 nucleotides and about 630 nucleotides in length 3 The isolated nucleic acid molecule of claim 1, wherein the LECl polynucleotide is SEQ ID No. 1 4 The isolated nucleic acid molecule of claim 1 , wherein the LECl polynucleotide encodes a LECl polypeptide of between about 50 and about 210 amino acids 5 The isolated nucleic acid molecule of claim 4, wherein the LECl polypeptide has an amino acid sequence as shown in SEQ ID No 2 6 The isolated nucleic acid molecule of claim 1, further comprising a plant promoter operably linked to the LECl polynucleotide 7 The isolated nucleic acid molecule of claim 6, wherein the plant promoter is from a LECl gene 8 The isolated nucleic acid of claim 7, wherein the LECl gene is as shown in SEQ ID No 3 9 The isolated nucleic acid of claim 7, wherein the LECl gene is as shown in SEQ ID No 4 10 The isolated nucleic acid of claim 7, wherein the LECl polynucleotide is linked to the promoter in an antisense orientation 11. An isolated nucleic acid molecule comprising a LECl polynucleotide sequence, which polynucleotide sequence encodes LECl polypeptide of between about 50 and about 210 amino acids. 12. The isolated nucleic acid of claim 10, wherein the LECl polypeptide has an amino acid sequence as shown in SEQ. ID. No. 2. 13. A transgenic plant comprising an expression cassette containing a plant promoter operably linked to a heterologous LECl polynucleotide that specifically hybridizes to SEQ. ID. No. 1 under stringent conditions. 14. The transgenic plant of claim 12, wherein the heterologous LECl polynucleotide encodes a LEC 1 polypeptide. 15. The transgenic plant of claim 13, wherein the LECl polypeptide is SEQ. ID. No. 2. 16. The transgenic plant of claim 12, wherein the heterologous LECl polynucleotide is linked to the promoter in an antisense orientation. 17. The transgenic plant of claim 12, wherein the plant promoter is from a LECl gene. 18. The transgenic plant of claim 16, wherein the LECl gene is as shown in SEQ. ID. No. 3. 19. The transgenic plant of claim 12, which is a member of the genus Brassica. 20. A method of modulating seed development in a plant, the method comprising introducing into the plant an expression cassette containing a plant promoter operably linked to a heterologous LECl polynucleotide that specifically hybridizes to SEQ. ID. No. 1 under stringent conditions. 21. The method of claim 19, wherein the heterologous LECl polynucleotide encodes a LECl polypeptide. 22. The method of claim 20, wherein the LECl polypeptide has an amino acid sequence as shown in SEQ. ID. No. 2. 23. The method of claim 19, wherein the heterologous LECl polynucleotide is linked to the promoter in an antisense orientation. 24. The method of claim 19, wherein the heterologous LECl polynucleotide is SEQ. ID. No. 1. 25. The method of claim 19, wherein the plant promoter is from a LECl gene. 26. The method of claim 19, wherein the LECl gene is as shown in SEQ. ID. No. 3. 27. The method of claim 19, wherein the plant is a member of the genus Brassica. 28. The method of claim 19, wherein the expression cassette is introduced into the plant through a sexual cross. 29. An isolated nucleic acid molecule comprising a plant promoter that specifically hybridizes to a polynucleotide sequence consisting of nucleotides 1 to 1998 of SEQ. ID. No. 3. 30. The isolated nucleic acid molecule of claim 28, wherein the plant promoter sequence consists essentially of nucleotides 1 to 1998 of SEQ. ID. No. 3. 31. The isolated nucleic acid molecule of claim 28, wherein the plant promoter sequence is a subsequence of SEQ. ID. No. 4. 32. The isolated nucleic acid molecule of claim 28, further comprising a polynucleotide sequence operably linked to the plant promoter sequence. 33. The isolated nucleic acid of claim 30, wherein the polynucleotide sequence operably linked to the plant promoter sequence encodes a desired polypeptide. 34. The isolated nucleic acid molecule of claim 28, wherein the polynucleotide sequence is linked to the promoter in an antisense orientation. 35. A transgenic plant comprising an expression cassette containing a LECl promoter operably linked to a heterologous polynucleotide sequence, wherein the LECl promoter specifically hybridizes to SEQ. ID. No. 3 under stringent conditions. 36. The transgenic plant of claim 33, wherein the polynucleotide sequence encodes a desired polypeptide. 37. The transgenic plant of claim 33, wherein the heterologous polynucleotide sequence is linked to the LECl promoter in an antisense orientation. 38. The transgenic plant of claim 33, wherein the LECl promoter is as shown in SEQ. ID. No. 3. 39. The transgenic plant of claim 33, which is a member of the genus Brassica. 40. A method of targeting expression of a polynucleotide to a seed, the method comprising introducing into a plant an expression cassette containing a LECl promoter operably linked to a heterologous polynucleotide sequence, wherein the LECl promoter specifically hybridizes to a polynucleotide sequence consisting of nucleotides 1 to 1998 of SEQ. ID. No. 3. 41. The method of claim 38, wherein the heterologous polynucleotide sequence encodes a desired polypeptide. 42. The method of claim 38, wherein the heterologous polynucleotide sequence is linked to the promoter in an antisense orientation.

Inventors: FISCHER ROBERT L, GOLDBERG ROBERT B, HARADA JOHN J, LOTAN TAMAR, OHTO MASA-AKI, FISCHER, ROBERT, L., GOLDBERG, ROBERT, B., HARADA, JOHN, J., LOTAN, TAMAR, OHTO, MASA-AKI
Applicants: UNIV CALIFORNIA, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Application year: 1998
Main classification: C12N15
IPC codes: C07K14, C12N15